News | May 12, 2023
Gilead acquires XinThera to strengthen pipeline in oncology
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
The blood test market worldwide is today around $75-80 billion
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Stedycon Sted super-resolution fluorescence microscope
The facility has been set up to manufacture tuberculosis testing cartridges
Proposed combination enhances Pfizer’s position as a leading company in oncology
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Subscribe To Our Newsletter & Stay Updated
